Erratum: Co-administration of cisplatin and furosemide causes rapid and massive loss of cochlear hair cells in mice (Neurotoxicity Research (2011) DOI 10.1007/s12640-011-9244-0);Co-administration of cisplatin and furosemide causes rapid and massive loss of cochlear hair cells in mice

Neurotoxicity Research

Volumn 20, Issue 4, 2011, Pages 307-319

  Li, Yongqi ^a,b   Ding, Dalian ^a   Jiang, Haiyan ^a   Fu, Yong ^a,c   Salvi, Richard ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cisplatin; Cochlea; Furosemide; Hair cell; Mouse; Ototoxicity

Indexed keywords

CISPLATIN; FUROSEMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDITORY THRESHOLD SHIFT; CELL LOSS; CONTROLLED STUDY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; EVOKED BRAIN STEM AUDITORY RESPONSE; HAIR CELL; HEARING LOSS; MOUSE; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; TOXICITY TESTING;

MURINAE; MUS; MUS MUSCULUS;

EID: 80053907759     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-011-9262-y     Document Type: Erratum

References (73)

1. JT Ahokas FA Nicholls PJ Ravenscroft BT Emmerson 1985 Inhibition of purified rat liver glutathione S-transferase isozymes by diuretic drugs Biochem Pharmacol 34 2157 2161 4004933 10.1016/0006-2952(85)90411-3 1:CAS:528: DyaL2MXks1ClsL4%3D (Pubitemid 15017078)
2. BW Blakley AK Gupta SF Myers S Schwan 1994 Risk factors for ototoxicity due to cisplatin Arch Otolaryngol Head Neck Surg 120 541 546 8172706 1:STN:280:DyaK2c3is1Orsg%3D%3D (Pubitemid 24142680)
3. BW Blakley J Hochman M Wellman A Gooi AE Hussain 2008 Differences in ototoxicity across species J Otolaryngol Head Neck Surg 37 700 703 19128679
4. WJ Bowers X Chen H Guo DR Frisina HJ Federoff RD Frisina 2002 Neurotrophin-3 transduction attenuates cisplatin spiral ganglion neuron ototoxicity in the cochlea Mol Ther 6 12 18 12095298 10.1006/mthe.2002.0627 1:CAS:528:DC%2BD38XltVGqsrg%3D (Pubitemid 36124265)
5. ZL Brookes NJ Brown CS Reilly 2000 Intravenous anaesthesia and the rat microcirculation: the dorsal microcirculatory chamber Br J Anaesth 85 901 903 11732528 10.1093/bja/85.6.901 1:CAS:528:DC%2BD3cXptVeis7Y%3D
6. ZL Brookes NJ Brown CS Reilly 2002 Differential effects of intravenous anaesthetic agents on the response of rat mesenteric microcirculation in vivo after haemorrhage Br J Anaesth 88 255 263 11883388 10.1093/bja/88.2.255 1:CAS:528:DC%2BD38XitFOnu78%3D (Pubitemid 34145004)
7. SS Byun SW Kim H Choi C Lee E Lee 2005 Augmentation of cisplatin sensitivity in cisplatin-resistant human bladder cancer cells by modulating glutathione concentrations and glutathione-related enzyme activities Br J Urol Int 95 1086 1090 1:CAS:528:DC%2BD2MXkvVWhsb4%3D (Pubitemid 40655712)
8. GD Chen MH Kermany A D'Elia M Ralli C Tanaka EC Bielefeld, et al. 2010 Too much of a good thing: long-term treatment with salicylate strengthens outer hair cell function but impairs auditory neural activity Hear Res 265 63 69 20214971 10.1016/j.heares.2010.02.010 1:CAS:528:DC%2BC3cXmtFahur0%3D
9. WJ Clerici K Hensley DL DiMartino DA Butterfield 1996 Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants Hear Res 98 116 124 8880186 10.1016/0378-5955(96)00075-5 1:CAS:528: DyaK28XmtVSqsLc%3D (Pubitemid 26306760)
10. DE Coling D Ding R Young M Lis E Stofko KM Blumenthal, et al. 2007 Proteomic analysis of cisplatin-induced cochlear damage: methods and early changes in protein expression Hear Res 226 140 156 17321087 10.1016/j.heares. 2006.12.017 1:CAS:528:DC%2BD2sXjsVemu7c%3D (Pubitemid 46428038)
11. PP Coradini L Cigana SG Selistre LS Rosito AL Brunetto 2007 Ototoxicity from cisplatin therapy in childhood cancer J Pediatr Hematol Oncol 29 355 360 17551394 10.1097/MPH.0b013e318059c220 1:CAS:528:DC%2BD2sXnvValtb4%3D (Pubitemid 46884215)
12. P Dallos D Harris 1978 Properties of auditory nerve responses in absence of outer hair cells J Neurophysiol 41 365 383 650272 1:STN:280: DyaE1c7ntlWrtA%3D%3D (Pubitemid 8318195)
13. DL Ding J Wang R Salvi D Henderson BH Hu SL McFadden, et al. 1999 Selective loss of inner hair cells and type-I ganglion neurons in carboplatin-treated chinchillas: mechanisms of damage and protection Ann N Y Acad Sci 884 152 170 10842592 10.1111/j.1749-6632.1999.tb08640.x 1:CAS:528:DC%2BD3cXhsV2htA%3D%3D
14. Ding D, McFadden SL, Salvi RJ (2001) Cochlear hair cell densities and inner ear staining techniques. In: Willott J (ed) The auditory psychobiology of the mouse. CRC Press, Boca Raton, FL, pp 189-204
15. D Ding SL McFadden JM Woo RJ Salvi 2002 Ethacrynic acid rapidly and selectively abolishes blood flow in vessels supplying the lateral wall of the cochlea Hear Res 173 1 9 12372630 10.1016/S0378-5955(02)00585-3 1:CAS:528:DC%2BD38Xns1Sjtbw%3D
16. D Ding A Stracher RJ Salvi 2002 Leupeptin protects cochlear and vestibular hair cells from gentamicin ototoxicity Hear Res 164 115 126 11950531 10.1016/S0378-5955(01)00417-8 1:CAS:528:DC%2BD38Xis1ens70%3D (Pubitemid 34285584)
17. D Ding SL McFadden RW Browne RJ Salvi 2003 Late dosing with ethacrynic acid can reduce gentamicin concentration in perilymph and protect cochlear hair cells Hear Res 185 90 96 14599696 10.1016/S0378-5955(03)00258-2 1:CAS:528:DC%2BD3sXos1Cnu7s%3D (Pubitemid 37346396)
18. D Ding H Jiang SL McFadden RJ Salvi 2004 Ethacrynic acid is the key for opening of the blood-labyrinth barrier Chin J Otol 1 42 47
19. D Ding H Jiang P Wang R Salvi 2007 Cell death after co-administration of cisplatin and ethacrynic acid Hear Res 226 129 139 16978814 10.1016/j.heares. 2006.07.015 1:CAS:528:DC%2BD2sXjsVemu7k%3D
20. D Ding W Qi M Zhang P Wang H Jiang R Salvi 2008 Cisplatin and its ototoxicity Chin J Otol 6 125 133
21. D Ding H Jiang RJ Salvi 2010 Mechanisms of rapid sensory hair-cell death following co-administration of gentamicin and ethacrynic acid Hear Res 259 16 23 19715747 10.1016/j.heares.2009.08.008 1:CAS:528:DC%2BC3cXjslKlug%3D%3D
22. A Forge 1976 Observations on the stria vascularis of the guinea pig cochlea and the changes resulting from the administration of the diuretic furosemide Clin Otolaryngol 1 211 219 1031348 10.1111/j.1365-2273.1976.tb00879.x 1:STN:280:DyaE1c%2Fkt1elsA%3D%3D (Pubitemid 8009855)
23. KK Grewal E Rafeiro WJ Racz 1996 Bromobenzene and furosemide hepatotoxicity: alterations in glutathione, protein thiols, and calcium Can J Physiol Pharmacol 74 257 264 8773404 1:CAS:528:DyaK28XjsVKhs74%3D (Pubitemid 26227496)
24. AM Guarino DS Miller ST Arnold JB Pritchard RD Davis MA Urbanek, et al. 1979 Platinate toxicity: past, present, and prospects Cancer Treat Rep 63 1475 1483 159127 1:CAS:528:DyaL3cXoslKguw%3D%3D (Pubitemid 10167742)
25. GW Harding BA Bohne JD Vos 2005 The effect of an age-related hearing loss gene (Ahl) on noise-induced hearing loss and cochlear damage from low-frequency noise Hear Res 204 90 100 15925194 10.1016/j.heares.2005.01.004 (Pubitemid 40733206)
26. J He S Yin J Wang D Ding H Jiang 2009 Effectiveness of different approaches for establishing cisplatin-induced cochlear lesions in mice Acta Otolaryngol 2009 1 9 10.1080/00016480902856604
27. HT Heidemann JF Gerkens EK Jackson RA Branch 1985 Attenuation of cisplatinum-induced nephrotoxicity in the rat by high salt diet, furosemide and acetazolamide Naunyn Schmiedebergs Arch Pharmacol 329 201 205 4040218 10.1007/BF00501213 1:CAS:528:DyaL2MXktFyjsLg%3D (Pubitemid 15078196)
28. GW Hill DK Morest K Parham 2008 Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections Otol Neurotol 29 1005 1011 18716567 10.1097/MAO.0b013e31818599d5
29. P Hofstetter D Ding N Powers RJ Salvi 1997 Quantitative relationship of carboplatin dose to magnitude of inner and outer hair cell loss and the reduction in distortion product otoacoustic emission amplitude in chinchillas Hear Res 112 199 215 9367242 10.1016/S0378-5955(97)00123-8 1:CAS:528: DyaK2sXntFSjtb8%3D (Pubitemid 27435996)
30. RS Huang S Duan SJ Shukla EO Kistner TA Clark TX Chen, et al. 2007 Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach Am J Hum Genet 81 427 437 17701890 10.1086/519850 1:CAS:528:DC%2BD2sXhtVSqur3K (Pubitemid 47330203)
31. HD Humes 1999 Insights into ototoxicity. Analogies to nephrotoxicity Ann N Y Acad Sci 884 15 18 10842580 1:CAS:528:DC%2BD3cXhsV2itw%3D%3D
32. M Izumikawa R Minoda K Kawamoto KA Abrashkin DL Swiderski DF Dolan, et al. 2005 Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals Nat Med 11 271 276 15711559 10.1038/nm1193 1:CAS:528:DC%2BD2MXhvVSru7g%3D (Pubitemid 40460554)
33. S Jamesdaniel D Ding MH Kermany BA Davidson PR Knight III R Salvi, et al. 2008 Proteomic analysis of the balance between survival and cell death responses in cisplatin-mediated ototoxicity J Proteome Res 7 3516 3524 18578524 10.1021/pr8002479 1:CAS:528:DC%2BD1cXns1yru7Y%3D
34. KR Johnson LC Erway SA Cook JF Willott QY Zheng 1997 A major gene affecting age-related hearing loss in C57BL/6J mice Hear Res 114 83 92 9447922 10.1016/S0378-5955(97)00155-X 1:CAS:528:DyaK1cXht1GktQ%3D%3D (Pubitemid 28007857)
35. SK Juhn LP Rybak 1981 Labyrinthine barriers and cochlear homeostasis Acta Otolaryngol 91 529 534 6791457 10.3109/00016488109138538 1:STN:280: DyaL3M3nvVCqsQ%3D%3D (Pubitemid 11064267)
36. JU Kim HJ Lee HH Kang JW Shin SW Ku JH Ahn, et al. 2005 Protective effect of isoflurane anesthesia on noise-induced hearing loss in mice Laryngoscope 115 1996 1999 16319612 10.1097/01.mlg.0000180173.81034.4d 1:CAS:528: DC%2BD2MXht1GksrnN (Pubitemid 44391663)
37. KR Knight DF Kraemer EA Neuwelt 2005 Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development J Clin Oncol 23 8588 8596 16314621 10.1200/JCO.2004.00.5355 (Pubitemid 46211500)
38. M Koch D De Backer JL Vincent L Barvais D Hennart D Schmartz 2008 Effects of propofol on human microcirculation Br J Anaesth 101 473 478 18653494 10.1093/bja/aen210 1:CAS:528:DC%2BD1cXhtFWhsrbJ
39. G Laurell B Engstrom 1989 The combined effect of cisplatin and furosemide on hearing function in guinea pigs Hear Res 38 19 26 2708156 10.1016/0378-5955(89)90124-X 1:CAS:528:DyaL1MXhvVGgurw%3D (Pubitemid 19076667)
40. G Laurell U Jungnelius 1990 High-dose cisplatin treatment: hearing loss and plasma concentrations Laryngoscope 100 724 734 2362532 10.1288/00005537- 199007000-00008 1:STN:280:DyaK3czgtVyqsw%3D%3D (Pubitemid 20222873)
41. JE Lee T Nakagawa TS Kim F Iguchi T Endo Y Dong, et al. 2003 A novel model for rapid induction of apoptosis in spiral ganglions of mice Laryngoscope 113 994 999 12782811 10.1097/00005537-200306000-00015 (Pubitemid 36676596)
42. JX Liu XN Zhou YG Yuan 1996 Effects of furosemide on intracochlear oxygen tension in the guinea pig Eur Arch Otorhinolaryngol 253 367 370 8858263 10.1007/BF00178294 1:STN:280:DyaK2s%2FhtFamsQ%3D%3D (Pubitemid 26258595)
43. D McAlpine BM Johnstone 1990 The ototoxic mechanism of cisplatin Hear Res 47 191 203 2228803 10.1016/0378-5955(90)90151-E 1:CAS:528:DyaK3MXjsFGhsw%3D%3D (Pubitemid 20244659)
44. SL McFadden D Ding RF Burkard H Jiang AG Reaume DG Flood, et al. 1999 Cu/Zn SOD deficiency potentiates hearing loss and cochlear pathology in aged 129, CD-1 mice J Comp Neurol 413 101 112 10464373 10.1002/(SICI)1096- 9861(19991011)413:1<101::AID-CNE7>3.0.CO;2-L 1:CAS:528:DyaK1MXmtVyku7w%3D (Pubitemid 29409754)
45. M Müller K von Hunerbein S Hoidis JW Smolders 2005 A physiological place-frequency map of the cochlea in the CBA/J mouse Hear Res 202 63 73 15811700 10.1016/j.heares.2004.08.011 (Pubitemid 40469771)
46. H Naito K Watanabe 1997 Alteration in capillary permeability of horseradish peroxidase in the stria vascularis and movement of leaked horseradish peroxidase after administration of furosemide ORL J Otorhinolaryngol Relat Spec 59 248 257 9279862 10.1159/000276948 1:STN:280:DyaK2svisFyisQ%3D%3D (Pubitemid 27374616)
47. V Natochin Yu LV Reznik VT Bakhteeva EM Myazina VK Brovtsyn 1989 Cisplatin: nephrotoxic action in vertebrates and its prevention Comp Biochem Physiol C 94 115 120 2576725 10.1016/0742-8413(89)90153-9 (Pubitemid 20047142)
48. EC Oesterle S Campbell 2009 Supporting cell characteristics in long-deafened aged mouse ears J Assoc Res Otolaryngol 10 525 544 19644644 10.1007/s10162-009-0183-x
49. EC Oesterle S Campbell RR Taylor A Forge CR Hume 2008 Sox2 and JAGGED1 expression in normal and drug-damaged adult mouse inner ear J Assoc Res Otolaryngol 9 65 89 18157569 10.1007/s10162-007-0106-7
50. KK Ohlemiller SL McFadden DL Ding DG Flood AG Reaume EK Hoffman, et al. 1999 Targeted deletion of the cytosolic Cu/Zn-superoxide dismutase gene (Sod1) increases susceptibility to noise-induced hearing loss Audiol Neuro-Otol 4 237 246 10.1159/000013847 1:CAS:528:DyaK1MXlsFShsr4%3D (Pubitemid 29366436)
51. J Oldenburg SM Kraggerud M Cvancarova RA Lothe SD Fossa 2007 Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors J Clin Oncol 25 708 714 17228018 10.1200/JCO.2006.08.9599 1:CAS:528:DC%2BD2sXjt1Knsr8%3D (Pubitemid 350002927)
52. J Oldenburg SD Fossa T Ikdahl 2008 Genetic variants associated with cisplatin-induced ototoxicity Pharmacogenomics 9 1521 1530 18855538 10.2217/14622416.9.10.1521 1:CAS:528:DC%2BD1cXht1Glu77I
53. HJ Park HJ Kim GS Bae SW Seo DY Kim WS Jung, et al. 2009 Selective GSK-3beta inhibitors attenuate the cisplatin-induced cytotoxicity of auditory cells Hear Res 257 53 62 19666099 10.1016/j.heares.2009.08.001 1:CAS:528:DC%2BD1MXht1WrtbvO
54. U Peters S Preisler-Adams A Hebeisen M Hahn E Seifert C Lanvers, et al. 2000 Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin Anticancer Drugs 11 639 643 11081456 10.1097/00001813-200009000-00007 1:CAS:528:DC%2BD3cXnsl2gsrk%3D
55. AL Poirrier P Van den Ackerveken TS Kim R Vandenbosch L Nguyen PP Lefebvre, et al. 2010 Ototoxic drugs: difference in sensitivity between mice and guinea pigs Toxicol Lett 193 41 49 20015469 10.1016/j.toxlet.2009.12.003 1:CAS:528:DC%2BC3cXhs1ynt7c%3D
56. MP Preckel C Ferber-Viart G Leftheriotis C Dubreuil R Duclaux JL Saumet, et al. 1998 Autoregulation of human inner ear blood flow during middle ear surgery with propofol or isoflurane anesthesia during controlled hypotension Anesth Analg 87 1002 1008 9806672 1:CAS:528:DyaK1cXntlehurY%3D (Pubitemid 28501148)
57. L Riedemann C Lanvers D Deuster U Peters J Boos H Jurgens, et al. 2008 Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin Pharmacogenomics J 8 23 28 17457342 10.1038/sj.tpj.6500455 1:CAS:528:DC%2BD1cXnt1Gmug%3D%3D
58. CJ Ross H Katzov-Eckert MP Dube B Brooks SR Rassekh A Barhdadi, et al. 2009 Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy Nat Genet 41 1345 1349 19898482 10.1038/ng.478 1:CAS:528:DC%2BD1MXhtlOrurjE
59. A Ryan P Dallos 1975 Effect of absence of cochlear outer hair cells on behavioural auditory threshold Nature 253 44 46 1110747 10.1038/253044a0 1:STN:280:DyaE2M%2Fot1ensw%3D%3D
60. LP Rybak CA Whitworth D Mukherjea V Ramkumar 2007 Mechanisms of cisplatin-induced ototoxicity and prevention Hear Res 226 157 167 17113254 10.1016/j.heares.2006.09.015 1:CAS:528:DC%2BD2sXjsVelsr4%3D (Pubitemid 46428033)
61. JT Santoso JA Lucci III RL Coleman I Schafer EV Hannigan 2003 Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial Cancer Chemother Pharmacol 52 13 18 12719883 10.1007/s00280-003-0620-1 1:CAS:528:DC%2BD3sXltVWgsb0%3D (Pubitemid 36920623)
62. MJ Schell VA McHaney AA Green LE Kun FA Hayes M Horowitz, et al. 1989 Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation J Clin Oncol 7 754 760 2715805 1:STN:280: DyaL1M3jsFKqtQ%3D%3D (Pubitemid 19145597)
63. NC Schmitt EW Rubel NM Nathanson 2009 Cisplatin-induced hair cell death requires STAT1 and is attenuated by epigallocatechin gallate J Neurosci 29 3843 3851 19321781 10.1523/JNEUROSCI.5842-08.2009 1:CAS:528:DC%2BD1MXktVSqtb8%3D
64. R Skinner 2004 Best practice in assessing ototoxicity in children with cancer Eur J Cancer 40 2352 2354 15519505 10.1016/j.ejca.2004.08.002 (Pubitemid 39424946)
65. H Versnel MJ Agterberg JC de Groot GF Smoorenburg SF Klis 2007 Time course of cochlear electrophysiology and morphology after combined administration of kanamycin and furosemide Hear Res 231 1 12 17475424 10.1016/j.heares.2007.03.003 1:CAS:528:DC%2BD2sXovFKrsrw%3D (Pubitemid 47211718)
66. TJ Walsh AW Clark IM Parhad WR Green 1982 Neurotoxic effects of cisplatin therapy Arch Neurol 39 719 720 6889850 1:STN:280:DyaL3s%2FitF2hug%3D%3D (Pubitemid 12003431)
67. J Wang S Ladrech R Pujol P Brabet TR Van De Water JL Puel 2004 Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss Cancer Res 64 9217 9224 15604295 10.1158/0008-5472.CAN-04-1581 1:CAS:528:DC%2BD2cXhtVOmsbzJ (Pubitemid 39665538)
68. K Watanabe S Inai K Jinnouchi S Bada A Hess O Michel, et al. 2002 Nuclear-factor kappa B (NF-kappa B)-inducible nitric oxide synthase (iNOS/NOS II) pathway damages the stria vascularis in cisplatin-treated mice Anticancer Res 22 4081 4085 12553036 1:CAS:528:DC%2BD3sXhtFGnu7s%3D (Pubitemid 36134437)
69. H Yamane Y Nakai 1988 Furosemide-induced alteration of drug pathway to cochlea Acta Otolaryngol Suppl 447 28 35 3055805 10.3109/00016488809102854 1:STN:280:DyaL1M%2Fks1Ghuw%3D%3D
70. M Zhang W Liu D Ding R Salvi 2003 Pifithrin-alpha suppresses p53 and protects cochlear and vestibular hair cells from cisplatin-induced apoptosis Neuroscience 120 191 205 12849752 10.1016/S0306-4522(03)00286-0 1:CAS:528:DC%2BD3sXkvFylt70%3D (Pubitemid 36782642)
71. ZY Zhang Z Zhang U Fauser M Artelt M Burnet HJ Schluesener 2007 Dexamethasone transiently attenuates up-regulation of endostatin/collagen XVIII following traumatic brain injury Neuroscience 147 720 726 17560042 10.1016/j.neuroscience.2007.04.052 1:CAS:528:DC%2BD2sXntFygtLc%3D (Pubitemid 46990648)
72. QY Zheng KR Johnson 2001 Hearing loss associated with the modifier of deaf waddler (mdfw) locus corresponds with age-related hearing loss in 12 inbred strains of mice Hear Res 154 45 53 11423214 10.1016/S0378-5955(01)00215-5 1:STN:280:DC%2BD3MzmvFKjtA%3D%3D (Pubitemid 32567533)
73. CL Zuur YJ Simis PE Lansdaal AA Hart JH Schornagel WA Dreschler, et al. 2007 Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer J Clin Oncol 25 3759 3765 17704425 10.1200/JCO.2006.08.9540 1:CAS:528:DC%2BD2sXhtVeqtL7M (Pubitemid 47372618)